Transcriptional profiling of fetal hypothalamic TRH neurons. 2011

Magdalena Guerra-Crespo, and Carlos Pérez-Monter, and Sarath Chandra Janga, and Santiago Castillo-Ramírez, and Rosa María Gutiérrez-Rios, and Patricia Joseph-Bravo, and Leonor Pérez-Martínez, and Jean-Louis Charli
Departamento de Genética y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México (UNAM), Cuernavaca, Morelos.

BACKGROUND During murine hypothalamic development, different neuroendocrine cell phenotypes are generated in overlapping periods; this suggests that cell-type specific developmental programs operate to achieve complete maturation. A balance between programs that include cell proliferation, cell cycle withdrawal as well as epigenetic regulation of gene expression characterizes neurogenesis. Thyrotropin releasing hormone (TRH) is a peptide that regulates energy homeostasis and autonomic responses. To better understand the molecular mechanisms underlying TRH neuron development, we performed a genome wide study of its transcriptome during fetal hypothalamic development. RESULTS In primary cultures, TRH cells constitute 2% of the total fetal hypothalamic cell population. To purify these cells, we took advantage of the fact that the segment spanning -774 to +84 bp of the Trh gene regulatory region confers specific expression of the green fluorescent protein (GFP) in the TRH cells. Transfected TRH cells were purified by fluorescence activated cell sorting, various cell preparations pooled, and their transcriptome compared to that of GFP- hypothalamic cells. TRH cells undergoing the terminal phase of differentiation, expressed genes implicated in protein biosynthesis, intracellular signaling and transcriptional control. Among the transcription-associated transcripts, we identified the transcription factors Klf4, Klf10 and Atf3, which were previously uncharacterized within the hypothalamus. CONCLUSIONS To our knowledge, this is one of the first reports identifying transcripts with a potentially important role during the development of a specific hypothalamic neuronal phenotype. This genome-scale study forms a rational foundation for identifying genes that might participate in the development and function of hypothalamic TRH neurons.

UI MeSH Term Description Entries
D007031 Hypothalamus Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE. Lamina Terminalis,Preoptico-Hypothalamic Area,Area, Preoptico-Hypothalamic,Areas, Preoptico-Hypothalamic,Preoptico Hypothalamic Area,Preoptico-Hypothalamic Areas
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D004622 Embryo, Mammalian The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS. Embryonic Structures, Mammalian,Mammalian Embryo,Mammalian Embryo Structures,Mammalian Embryonic Structures,Embryo Structure, Mammalian,Embryo Structures, Mammalian,Embryonic Structure, Mammalian,Embryos, Mammalian,Mammalian Embryo Structure,Mammalian Embryonic Structure,Mammalian Embryos,Structure, Mammalian Embryo,Structure, Mammalian Embryonic,Structures, Mammalian Embryo,Structures, Mammalian Embryonic
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D000090062 Kruppel-Like Factor 4 A member of zinc finger-containing transcription factors that belongs to the KRUPPEL-LIKE FACTOR family, involved in the regulation of diverse cellular processes such as cell growth, proliferation, differentiation, and APOPTOSIS. EZF Protein,Endothelial Kruppel-Like Zinc Finger Protein,Epithelial Zinc Finger Protein,GKLF Protein,Gut-Enriched Kruppel-Like Factor,Klf4 Protein,Krueppel-Like-Factor 4,4, Krueppel-Like-Factor,4, Kruppel-Like Factor,Endothelial Kruppel Like Zinc Finger Protein,Factor 4, Kruppel-Like,Factor, Gut-Enriched Kruppel-Like,Gut Enriched Kruppel Like Factor,Kruppel Like Factor 4,Protein, EZF,Protein, GKLF,Protein, Klf4
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013973 Thyrotropin-Releasing Hormone A tripeptide that stimulates the release of THYROTROPIN and PROLACTIN. It is synthesized by the neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, TRH (was called TRF) stimulates the release of TSH and PRL from the ANTERIOR PITUITARY GLAND. Protirelin,Thyroliberin,Abbott-38579,Antepan,Proterelin Tartrate,Proterelin Tartrate Hydrate,Protirelin Tartrate (1:1),Relefact TRH,Stimu-TSH,TRH Ferring,TRH Prem,Thypinone,Thyroliberin TRH Merck,Thyrotropin-Releasing Factor,Thyrotropin-Releasing Hormone Tartrate,Abbott 38579,Abbott38579,Hydrate, Proterelin Tartrate,Prem, TRH,Stimu TSH,StimuTSH,TRH, Relefact,Tartrate Hydrate, Proterelin,Thyrotropin Releasing Factor,Thyrotropin Releasing Hormone,Thyrotropin Releasing Hormone Tartrate
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

Magdalena Guerra-Crespo, and Carlos Pérez-Monter, and Sarath Chandra Janga, and Santiago Castillo-Ramírez, and Rosa María Gutiérrez-Rios, and Patricia Joseph-Bravo, and Leonor Pérez-Martínez, and Jean-Louis Charli
January 1987, General pharmacology,
Magdalena Guerra-Crespo, and Carlos Pérez-Monter, and Sarath Chandra Janga, and Santiago Castillo-Ramírez, and Rosa María Gutiérrez-Rios, and Patricia Joseph-Bravo, and Leonor Pérez-Martínez, and Jean-Louis Charli
January 1986, Experimental brain research,
Magdalena Guerra-Crespo, and Carlos Pérez-Monter, and Sarath Chandra Janga, and Santiago Castillo-Ramírez, and Rosa María Gutiérrez-Rios, and Patricia Joseph-Bravo, and Leonor Pérez-Martínez, and Jean-Louis Charli
January 2024, Reproduction (Cambridge, England),
Magdalena Guerra-Crespo, and Carlos Pérez-Monter, and Sarath Chandra Janga, and Santiago Castillo-Ramírez, and Rosa María Gutiérrez-Rios, and Patricia Joseph-Bravo, and Leonor Pérez-Martínez, and Jean-Louis Charli
March 2021, BMC genomics,
Magdalena Guerra-Crespo, and Carlos Pérez-Monter, and Sarath Chandra Janga, and Santiago Castillo-Ramírez, and Rosa María Gutiérrez-Rios, and Patricia Joseph-Bravo, and Leonor Pérez-Martínez, and Jean-Louis Charli
December 2009, Brain research,
Magdalena Guerra-Crespo, and Carlos Pérez-Monter, and Sarath Chandra Janga, and Santiago Castillo-Ramírez, and Rosa María Gutiérrez-Rios, and Patricia Joseph-Bravo, and Leonor Pérez-Martínez, and Jean-Louis Charli
November 2018, European thyroid journal,
Magdalena Guerra-Crespo, and Carlos Pérez-Monter, and Sarath Chandra Janga, and Santiago Castillo-Ramírez, and Rosa María Gutiérrez-Rios, and Patricia Joseph-Bravo, and Leonor Pérez-Martínez, and Jean-Louis Charli
April 1979, Physiology & behavior,
Magdalena Guerra-Crespo, and Carlos Pérez-Monter, and Sarath Chandra Janga, and Santiago Castillo-Ramírez, and Rosa María Gutiérrez-Rios, and Patricia Joseph-Bravo, and Leonor Pérez-Martínez, and Jean-Louis Charli
September 2001, Brain research. Developmental brain research,
Magdalena Guerra-Crespo, and Carlos Pérez-Monter, and Sarath Chandra Janga, and Santiago Castillo-Ramírez, and Rosa María Gutiérrez-Rios, and Patricia Joseph-Bravo, and Leonor Pérez-Martínez, and Jean-Louis Charli
September 2022, STAR protocols,
Magdalena Guerra-Crespo, and Carlos Pérez-Monter, and Sarath Chandra Janga, and Santiago Castillo-Ramírez, and Rosa María Gutiérrez-Rios, and Patricia Joseph-Bravo, and Leonor Pérez-Martínez, and Jean-Louis Charli
October 1995, Brain research. Developmental brain research,
Copied contents to your clipboard!